Skip to content
10-Q

Quarterly Report

PARATEK PHARMACEUTICALS, INC.

0001178711-22-000016

← back to feed
Filed
Nov 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Oct 31, 2022 55.55M sh
Shares Diluted Q3 2022 · Sep 30, 2022 55.17M sh
Shares Diluted Q3 2022 · Sep 30, 2022 53.93M sh
Shares Diluted Q3 2022 · Sep 30, 2021 49.21M sh
Shares Diluted Q3 2022 · Sep 30, 2021 47.68M sh
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$46.03M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$28.47M
Long Term Debt Q3 2022 · Sep 30, 2022 $258.48M
Long Term Debt Q3 2022 · Dec 31, 2021 $254.43M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $27.09M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $80.37M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $111M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$166.15M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$149.37M
Stockholders Equity Q3 2022 · Mar 31, 2022 −$140.3M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$127.79M
Stockholders Equity Q3 2022 · Sep 30, 2021 −$104.99M
Stockholders Equity Q3 2022 · Jun 30, 2021 −$99.29M
Stockholders Equity Q3 2022 · Mar 31, 2021 −$119.01M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$102.26M
Current Liabilities Q3 2022 · Sep 30, 2022 $38.98M
Current Liabilities Q3 2022 · Dec 31, 2021 $31.3M
Total Liabilities Q3 2022 · Sep 30, 2022 $323.47M
Total Liabilities Q3 2022 · Dec 31, 2021 $311.66M
Current Assets Q3 2022 · Sep 30, 2022 $121.34M
Current Assets Q3 2022 · Dec 31, 2021 $152.1M
Total Assets Q3 2022 · Sep 30, 2022 $157.32M
Total Assets Q3 2022 · Dec 31, 2021 $183.87M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.38
Eps Diluted Q3 2022 · Sep 30, 2022 −$1.05
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.37
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.56
Eps Basic Q3 2022 · Sep 30, 2022 −$0.38
Eps Basic Q3 2022 · Sep 30, 2022 −$1.05
Eps Basic Q3 2022 · Sep 30, 2021 −$0.37
Eps Basic Q3 2022 · Sep 30, 2021 −$0.56
Sga Expense Q3 2022 · Sep 30, 2022 $33.85M
Sga Expense Q3 2022 · Sep 30, 2022 $91.78M
Sga Expense Q3 2022 · Sep 30, 2021 $25.96M
Sga Expense Q3 2022 · Sep 30, 2021 $75.42M
Net Income Q3 2022 · Sep 30, 2022 −$20.88M
Net Income Q3 2022 · Sep 30, 2022 −$56.41M
Net Income Q3 2022 · Jun 30, 2022 −$17.62M
Net Income Q3 2022 · Mar 31, 2022 −$17.91M
Net Income Q3 2022 · Sep 30, 2021 −$18.2M
Net Income Q3 2022 · Sep 30, 2021 −$26.83M
Net Income Q3 2022 · Jun 30, 2021 $9.72M
Net Income Q3 2022 · Mar 31, 2021 −$18.35M
Operating Income Q3 2022 · Sep 30, 2022 −$16.49M
Operating Income Q3 2022 · Sep 30, 2022 −$43.37M
Operating Income Q3 2022 · Sep 30, 2021 −$13.72M
Operating Income Q3 2022 · Sep 30, 2021 −$13.85M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $4.37M
Cost Of Revenue Q3 2022 · Sep 30, 2022 $12.74M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $4.29M
Cost Of Revenue Q3 2022 · Sep 30, 2021 $16.82M
Revenue Q3 2022 · Sep 30, 2022 $30.21M
Revenue Q3 2022 · Sep 30, 2022 $84.71M
Revenue Q3 2022 · Sep 30, 2021 $24.45M
Revenue Q3 2022 · Sep 30, 2021 $98.37M